MedPath

DUTA WACANA CHRISTIAN UNIVERSITY

🇮🇩Indonesia
Ownership
-
Established
1962-01-01
Employees
-
Market Cap
-
Website
https://www.ukdw.ac.id

Clinical Trials

5

Active:1
Completed:0

Trial Phases

2 Phases

Phase 2:4
Phase 4:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials

Phase 2
4 (80.0%)
Phase 4
1 (20.0%)

Effect of Eurycoma Longifolia (DLBS5055) and Multivitamins (Vitamin C+Vitamin E+ Β-carotene) for Infertile Males

Phase 4
Active, not recruiting
Conditions
Male Infertility
Interventions
Drug: DLBS5055 200mg
Drug: Placebo DLBS5055
Drug: Multivitamin (Vitamin C 500mg + Vitamin E 100IU + Beta Carotene 10000IU)
Drug: Placebo Multivitamin
First Posted Date
2023-10-25
Last Posted Date
2025-03-27
Lead Sponsor
Duta Wacana Christian University
Target Recruit Count
90
Registration Number
NCT06100432
Locations
🇮🇩

Laboratorium Klinik Pramita, Yogyakarta, Indonesia

The Benefits of Vitamin B Combination as Add on Therapy in the Management of Painful Diabetic Neuropathy Patient

Phase 2
Conditions
Painful Diabetic Neuropathy
Interventions
Drug: Standard therapy
Drug: Vitamin B combination
First Posted Date
2020-12-30
Last Posted Date
2020-12-30
Lead Sponsor
Duta Wacana Christian University
Target Recruit Count
60
Registration Number
NCT04689971
Locations
🇮🇩

Bethesda Hospital Yogyakarta, Yogyakarta, Special Region Of Yogyakarta, Indonesia

The Benefits of Vitamin D 5000 IU as Add on Therapy in the Management of Painful Diabetic Neuropathy Patient

Phase 2
Conditions
Painful Diabetic Neuropathy
Interventions
First Posted Date
2020-12-30
Last Posted Date
2020-12-30
Lead Sponsor
Duta Wacana Christian University
Target Recruit Count
60
Registration Number
NCT04689958
Locations
🇮🇩

Bethesda Hospital Yogyakarta, Yogyakarta, Special Region Of Yogyakarta, Indonesia

The Benefits of Astaxanthin as Add on Therapy in the Management of Painful Diabetic Neuropathy Patient

Phase 2
Conditions
Painful Diabetic Neuropathy
Interventions
Drug: Standard therapy
First Posted Date
2020-12-30
Last Posted Date
2020-12-30
Lead Sponsor
Duta Wacana Christian University
Target Recruit Count
60
Registration Number
NCT04689984
Locations
🇮🇩

Bethesda Hospital Yogyakarta, Yogyakarta, Special Region Of Yogyakarta, Indonesia

The Benefit of Add On DLBS1033 for Ischemic Stroke Patient

Phase 2
Conditions
Ischemic Stroke
Interventions
First Posted Date
2020-06-11
Last Posted Date
2020-06-11
Lead Sponsor
Duta Wacana Christian University
Target Recruit Count
180
Registration Number
NCT04425590
Locations
🇮🇩

Bethesda Hospital Yogyakarta, Yogyakarta, Special Region Of Yogyakarta, Indonesia

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.